Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» sickle cell disease
sickle cell disease
Novartis drug cuts serious complications in sickle cell disease
CP WIre
Wed, 10/10/18 - 10:15 am
Novartis
sickle cell disease
crizanlizumab
GBT touts positive sickle cell trial, but shares yo-yo as investors mull data
Fierce Biotech
Wed, 06/27/18 - 12:01 pm
Global Blood Therapeutics
sickle cell disease
voxelotor
clinical trials
Bluebird Bio Announces More Good News for LentiGlobin Gene Therapy – Exciting Results in Sickle Cell Disease
CP Wire
Fri, 06/15/18 - 10:02 am
Bluebird Bio
sickle cell disease
LentiGlobin
gene therapy
Bluebird Bio Presents Promising Results for Gene Therapy in Rare Blood Disorder
CP Wire
Fri, 06/15/18 - 10:01 am
Bluebird Bio
gene therapy
LentiGlobin
beta thalassemia
sickle cell disease
Bluebird Bio Announces More Good News for LentiGlobin Gene Therapy – Exciting Results in Sickle Cell Disease
Fri, 06/15/18 - 09:51 am
Bluebird Bio
sickle cell disease
LentiGlobin
Bluebird Bio Presents Promising Results for Gene Therapy in Rare Blood Disorder
Fri, 06/15/18 - 09:39 am
Bluebird Bio
β-thalassemia
sickle cell disease
LentiGlobin
Ironwood Pharma’s Sickle Cell Drug Gets Orphan Drug Designation
BioSpace
Sun, 06/10/18 - 07:03 pm
Ironwood Pharmaceuticals
FDA
sickle cell disease
olinciguat
orphan drug
FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study
Xconomy
Wed, 05/30/18 - 08:58 pm
sickle cell disease
FDA
Vertex Pharmaceuticals
CRISPR Therapeutics
CTX001
stem cells
Novo charts course for sickle cell amid headwinds in hemophilia
Biopharma Dive
Thu, 04/5/18 - 11:47 pm
Novo Nordisk
sickle cell disease
hemophilia
EPI01
EpiDestiny
This could be the next $1 billion drug, if patients get on board
Yahoo/Marketwatch
Tue, 02/27/18 - 09:55 am
sickle cell disease
Rivipansel
Pfizer
clinical trials
Bluebird’s tweaked sickle cell gene therapy clears early test
Fierce Biotech
Wed, 11/1/17 - 06:42 pm
Bluebird Bio
sickle cell disease
gene therapy
HGB-206
Bioverativ and Bicycle keep rare disease deals rolling
BioPharma Dive
Thu, 09/7/17 - 09:39 am
Bioverativ
Bicycle Therapeutics
R&D
drug development
sickle cell disease
hemophilia
Emmaus who? A biotech you never heard of just won an historic drug OK for sickle cell disease
Endpoints
Sat, 07/8/17 - 09:59 am
Emmaus Life Sciences
sickle cell disease
Emari
FDA
Drug Makers Take Page From Hollywood to Spread the Risk
FOX Business
Sun, 04/30/17 - 12:45 pm
Pfizer
Rivipansel
sickle cell disease
clinical trials
What makes a PhII drug worth up to $665M? Researchers spell it out for Novartis
Endpoints
Mon, 12/5/16 - 09:48 am
Novartis
crizanlizumab
sickle cell disease
M&A
Selexys
Sangamo to transfer two gene therapies to Biogen spin-off
BioPharma Dive
Thu, 12/1/16 - 04:24 pm
Sangamo
gene therapy
Biogen
Bioverativ
sickle cell disease
beta-thalassemia
Novartis buys sickle cell player Selexys in $665M deal
Fierce Biotech
Mon, 11/21/16 - 11:34 am
Novartis
Selexys
M&A
sickle cell disease
Why CRISPR Is An Attractive Approach To Treat Sickle Cell Disease
Forbes
Mon, 08/15/16 - 09:48 pm
CRISPR
sickle cell disease
Editas Medicine
Novartis
Intellia Therapeutics
Shares in Global Blood climb after positive study results for experimental sickle cell treatment
First Word Pharma
Fri, 06/10/16 - 10:21 am
Global Blood Therapeutics
GBT440
sickle cell disease
The Big News For Sickle Cell Anemia Is Not Gene Therapy
Forbes
Tue, 12/15/15 - 09:56 am
gene therapy
sickle cell disease
Global Blood Therapeutics
GBT440
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »